Who
Flavio Mantelli
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, OKYO Pharma.
In numbers
- Trades disclosed
- 4
- Buys
- 1
- Sells
- 0
- Bought
- $56K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Jul 2026
- Last trade
- 21 Jul 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Jul – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jul 2026filed 7 Aug 2026 | OKYO OKYO PharmaBiotechnology | SEC FORM 4 Bought | $28K20,000 at $1.40 | filing |
| 21 Jul 2026filed 7 Aug 2026 | OKYO OKYO PharmaBiotechnology | SEC FORM 4 Bought | $28K20,000 at $1.40 | filing |
| 21 Jul 2026filed 22 Jul 2026 | OKYO OKYO PharmaBiotechnology | SEC FORM 4 Code A | $28K20,000 at $1.40 | filing |
| 21 Jul 2026filed 22 Jul 2026 | OKYO OKYO PharmaBiotechnology | SEC FORM 4 Code A | $28K20,000 at $1.40 | filing |
News
No headline names them, or the companies they trade most, lately.